Patents/Assignees

Bliss Biopharmaceutical (Hangzhou) Co., Ltd.

3 patents in portfolio

US12605457utility2026
Modified EGFR Antibody with Reduced Affinity, Drug Conjugate, and Use Thereof
0 cites
US12024565utility2024
Targeted CD73 Antibody and Antibody-drug Conjugate, and Preparation Method Therefor and Uses Thereof
0 cites
US11951173utility2024
Tetravalent Antibody-drug Conjugates and Use Thereof
0 cites